Catalyst Wire Dossier Catalyst Wire Dossier

BONDLIDO

Lidocaine · MEDRx USA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BONDLIDO, covering 2025-09-24 to 2025-09-24. Get the full timeline:

Most recent: FDA Approved: BONDLIDO — Original Application (MEDRx USA, Inc.)

See pricing